MuzaffarH.QazilbashMD

PubMed

• Stability of Captisol-enabled versus propylene glycol-based melphalan at room temperature and after refrigeration.
  Jitesh D Kawedia, Sumankalai Ramchandran, Xiaoqian Liu, Alison M Gulbis, Mark Titus, Qaiser Bashir, Muzaffar H Qazilbash, Richard E Champlin, Stefan O Ciurea> ;American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022 Jun 7
• Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?
  Rohtesh S Mehta, Rima M Saliba, Eiko Hayase, Robert R Jenq, Susan Abraham, Asif Rashid, Gabriela Rondon, Gheath Al-Atrash, Qaiser Bashir, Chitra M Hosing, Partow Kebri...> ;Transplantation and cellular therapy. 2022 May 31
• Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leuk...
  Gheath Alatrash, Chantal Saberian, Roland Bassett, Peter F Thall, Celina Ledesma, Yoshimi Lu, May Daher, Benigno C Valdez, Jitesh Kawedia, Uday Popat, Rohtesh Mehta, B...> ;Transplantation and cellular therapy. 2022 May 23
• Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
  Aimaz Afrough, Leonard C Alsfeld, Denái R Milton, Ruby Delgado, Uday R Popat, Yago Nieto, Partow Kebriaei, Betul Oran, Neeraj Saini, Samer Srour, Chitra Hosing, Faisal...> ;Transplantation and cellular therapy. 2022 May 20
• Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
  Anita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, Marcelo C Pasquini, Parameswaran Hari, Asad Bashey, Natalie Callander, Steven Devine, Yvonne Efebera, Siddhartha G...> ;American journal of hematology. 2022 May 14
• KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma.
  Mahmoud R Gaballa, Junsheng Ma, Mikael Rauf, Roland Bassett, Oren Pasvolsky, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy Ramdial, Yago Nieto, Reg...> ;Bone marrow transplantation. 2022 May 6
• Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma.
  Ankit Kansagra, Angela Dispenzieri, Raphael Fraser, Noel Estrada-Merly, Surbhi Sidana, Taiga Nishihori, Doris K Hansen, Larry D Anderson Jr, Rahul Banerjee, Naresh Bum...> ;Blood advances. 2022 May 4
• Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
  Rohtesh S Mehta, Rima M Saliba, Sassine Ghanem, Amin M Alousi, Gabriela Rondon, Paolo Anderlini, Gheath Al-Atrash, Qaiser Bashir, Chitra M Hosing, Jin S Im, Partow Keb...> ;Transplantation and cellular therapy. 2022 May 2
• Financial toxicity in hematological malignancies: a systematic review.
  Evguenia Ouchveridze, Rahul Banerjee, Aakash Desai, Muhammad Aziz, Wade Lee-Smith, Hira Mian, Katherine Berger, Brian McClune, Douglas Sborov, Muzaffar Qazilbash, Shaj...> ;Blood cancer journal. 2022 Apr 22
• Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.
  Serkan Akin, Chitra Hosing, Issa Khouri, Sairah Ahmed, Amin Alousi, Nathan Fowler, Jacinth Joseph, Jonathan Truxillo, Jeremy L Ramdial, Farzaneh Maadani, Gabriela Rond...> ;Blood advances. 2022 Apr 12
• 2 citations
  Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).
  Angela Dispenzieri, Amrita Krishnan, Bonnie Arendt, Beth Blackwell, Paul K Wallace, Surendra Dasari, Dan T Vogl, Yvonne Efebera, Mingwei Fei, Nancy Geller, Sergio Gira...> ;Blood cancer journal. 2022 Feb 10
• 1 citations
  Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
  C. Cameron Yin, Naveen Pemmaraju, M. James You, Shaoying Li, Jie Xu, Wei Wang, Zhenya Tang, Omar Alswailmi, Kapil N. Bhalla, Muzaffar H. Qazilbash, Marina Konopleva, J...> ;Cancers. 2021 Nov 23
• A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients.
  Carlyn Tan, Noel Estrada-Merly, Heather Landau, Lazaros J. Lekakis, Rahul Banerjee, Hira S. Mian, Saad Z. Usmani, Amr Hanbali, Hillard M. Lazarus, Robert A. Kyle, Bhag...> ;Bone Marrow Transplantation. 2021 Nov 20
• 1 citations
  Title: Impact of Induction Therapy with VRD vs. VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell...
  Surbhi Sidana, Shaji Kumar, Raphael Fraser, Noel Estrada-Merly, Sergio Giralt, Vaibhav Agrawal, Larry D. Anderson, Mahmoud Aljurf, Rahul Banerjee, Asad Bashey, Minoo B...> ;Transplantation and cellular therapy. 2021 Nov 12
• Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation.
  Sairah Ahmed, Qiuhong Zhao, Walter Hanel, Muzaffar H. Qazilbash, Krina K. Patel, Ravi Narra, Ankit Kansagra, Madiha Iqbal, Farrukh T. Awan, Beth Christian, Samantha Ja...> ;Hematological Oncology. 2021 Nov 11
• 1 citations
  Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical Trial.
  Rohtesh S. Mehta, Roland L. Bassett, Julianne Chen, Benigno C. Valdez, Jitesh D. Kawedia, Amin M. Alousi, Paolo Anderlini, Gheath Alatrash, Qaiser Bashir, Stefan O. Ci...> ;Transplantation and cellular therapy. 2021 Nov 1
• 1 citations
  Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance
  Mahmoud R Gaballa, Junsheng Ma, Mark R Tanner, Taha Al-Juhaishi, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy L Ramdial, Yago Nieto, Regan Murphy, Katayoun Rezva...> ;Leukemia & Lymphoma. 2021 Oct 22
• 7 citations
  Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm.
  Naveen Pemmaraju, Nathaniel R. Wilson, Joseph D. Khoury, Nitin Jain, Naval Daver, Sherry Pierce, Elias Jabbour, Tapan M. Kadia, Courtney D. DiNardo, Guillermo Garcia-M...> ;Blood. 2021 Oct 14
• 6 citations
  Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
  Qaiser Bashir, Denái R. Milton, Uday R. Popat, Partow Kebriaei, Chitra Hosing, Issa F. Khouri, Katayoun Rezvani, Yago Nieto, Betul Oran, Samer A. Srour, Neeraj Saini, ...> ;Bone Marrow Transplantation. 2021 Oct 11
• 1 citations
  Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis
  Oren Pasvolsky, Moshe Yeshurun, Raphael Fraser, Noel Estrada-Merly, Uri Rozovski, Liat Shargian-Alon, Amer Assal, Rahul Banerjee, Naresh Bumma, Robert Peter Gale, Patr...> ;Bone Marrow Transplantation. 2021 Oct 4
• 1 citations
  Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to whites: a propensity-score matched analysis
  Romil Patel, Junsheng Ma, Qaiser Bashir, Ruby Delgado, Gabriela Rondon, Uday R. Popat, Chitra Hosing, Yago Nieto, Partow Kebriaei, Amin M. Alousi, May Daher, Rohtesh S...> ;American Journal of Hematology. 2021 Sep 24
• 2 citations
  Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
  Rohtesh S. Mehta, Rima M. Saliba, Leonard C. Alsfeld, Jeffrey L. Jorgensen, Sa A. Wang, Paolo Anderlini, Gheath Alatrash, Qaiser Bashir, Stefan O. Ciurea, Chitra Hosin...> ;Transplantation and cellular therapy. 2021 Sep 16
• 1 citations
  A Randomized Phase II Trial of Idiotype Vaccination and Adoptive Autologous T-Cell Transfer in Multiple Myeloma patients.
  Muzaffar H. Qazilbash, Neeraj Saini, Cha Soung-chul, Zhe Wang, Edward A. Stadtmauer, Veerabhadran Baladandayuthapani, Heather Lin, Beryl Tross, Medhavi Honhar, Sheetal...> ;Blood. 2021 Sep 14
• Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma.
  Samer A. Srour, Denái R. Milton, Qaiser Bashir, Yago Nieto, Neeraj Saini, May Daher, Jeremy Ramdial, Jin Im, Chitra Hosing, Ruby Delgado, Elisabet E. Manasanch, Hans C...> ;Haematologica. 2021 Aug 19
• Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant.
  Issa F. Khouri, Denái R. Milton, Alison M. Gulbis, Elias Jabbour, Loretta J. Nastoupil, Celina Ledesma, Paolo Anderlini, Qaiser Bashir, May Daher, Jin S. Im, Swaminath...> ;Clinical Cancer Research. 2021 Aug 11
• Join now to see all

Journal Articles

• Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
  Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
• Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...  
  Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature

Abstracts/Posters

• Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics ...
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018